Juan Ortega Perez's research while affiliated with Hospital Universitari Son Espases and other places

What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.

It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.

If you're a ResearchGate member, you can follow this page to keep up with this author's work.

If you are this author, and you don't want us to display this page anymore, please let us know.

Publications (8)

Figure 1: Flow chart
Cannabis clinical features by age and sex 1 Differences in clinical features associated with cannabis intoxication in presentations to European emergency departments according to patient age and sex Cannabis clinical features by age and sex 2 First name Middle name Last/family name Affiliation
Article
Full-text available
  • Mar 2023
Objective: To investigate if clinical features associated with acute cannabis intoxication in patients presenting to Emergency Departments for medical assistance differ according to patient age and sex. Methods: We analysed presentations in the Euro-DEN Plus dataset from 2014-2019 in which cannabis was the only drug involved (except for alcohol), a...
Cite
Download full-text
Ketamine detection in urine samples from patients poisoned by recreational drugs: epidemiologic, clinical, and toxicologic profiles
Article
  • Feb 2023
Objectives: To describe the epidemiologic, clinical, and toxicologic profiles of patients who used recreational ketamine and experienced acute poisoning. Material and methods: Retrospective observational study of patients attended by several emergency medical services in the Balearic Islands for analytically confirmed acute poisoning after using...
Cite
Request full-text
Cite
Request full-text
Figura 3. Representación de las curvas spline cúbicas restringidas...
Clinical manifestations and serious adverse effects after cannabis use: role of age according to sex and coingestion of alcohol
Article
Full-text available
  • Aug 2022
Objectives: To study whether there are age-related differences in the clinical effects of cannabis poisoning and whether any age differences found are also related to sex or coingestion of alcohol. Material and methods: Descriptive observational study of patients treated in 11 emergency departments for symptoms related to cannabis use. We collec...
Cite
Download full-text
Figura 3. Representación de las curvas spline cúbicas restringidas...
Manifestaciones clínicas y eventos adversos graves tras consumo de cannabis: efecto de la edad y análisis diferenciado en función del sexo y la coingesta de etanol
Article
Full-text available
  • Aug 2022
4 , en representación de la Red de Estudio de Drogas en Urgencias Hospitalarias en España (REDUrHE) Objetivo. Investigar si existen diferencias en las manifestaciones clínicas por consumo de cannabis según la edad, y si estas se modifican en función del sexo o el consumo de etanol. Método. Estudio observacional descriptivo de pacientes atendidos en...
Cite
Download full-text
Cite
Request full-text
Cite
Request full-text
Cite
Request full-text

Citations

... 15 Whereas the Euro-Den Plus project data evidenced that emergency hospital presentations related to tramadol abuse in a context of non-medical use were lower than for other opioids, a great variability has been observed in sentinel hospitals across Europe for 2014-2017. 16 Tramadol is currently not on the list of controlled substances regulated by the International Narcotics Control Board. In France, tramadol is a prescription-only medicine. ...
Reference: Increase of high‐risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance data
View
... In addition, participants consisted of a large number of recreational users who reported using MDMA/Ecstasy always or often within the context of electronic dance music events (36 %), music festivals (34 %), house parties (18 %), concert venues (13 %), or nightclubs and bars (12 %), where energy might be a more salient motive than for users choosing to use at home or a friend's home (36 %). Prior research indicates that MDMA/Ecstasy is almost exclusively used in a polysubstance context (Noseda et al., 2021). Therefore, it is possible that recreational Ecstasy users may have divergent motives for other substances relative to non-MDMA users and as such, there may be significant conceptual overlap with their motives for using other substances. ...
Reference: Development and initial validation of an MDMA/Ecstasy motives assessment
View
... Conociéndose ya a nivel fisiopatológico los efectos secundarios cardiovasculares del cannabis, tanto agudos 10,11 como crónicos 12 , creemos que es necesario en el screening toxicológico a pacientes con síndrome coronario agudo incluir su detección 13 . Además, es destacable que consuman más de una sustancia el 39% de los pacientes del estudio 14 . ...
Reference: Dolor torácico secundario al consumo de drogas atendido en urgencias hospitalarias en España
View full-text